Cantabio completes private placement of convertible debentures

On Feb. 2, neurodegenerative disease company Cantabio Pharmaceuticals Inc. (OTCQB:CTBO) raised $300,000 in debentures in the first tranche of a planned $600,000 private placement with Yorkville Advis...